Literature DB >> 22425584

ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.

Sangphil Oh1, Sook Shin, Ralf Janknecht.   

Abstract

The homologous ETV1, ETV4 and ETV5 proteins form the PEA3 subfamily of ETS transcription factors. In Ewing tumors, chromosomal translocations affecting ETV1 or ETV4 are an underlying cause of carcinogenesis. Likewise, chromosomal rearrangements of the ETV1, ETV4 or ETV5 gene occur in prostate tumors and are thought to be one of the major driving forces in the genesis of prostate cancer. In addition, these three ETS proteins are implicated in melanomas, breast and other types of cancer. Complex posttranslational modifications govern the activity of PEA3 factors, which can promote cell proliferation, motility and invasion. Here, we review evidence for a role of ETV1, 4 and 5 as oncoproteins and describe modes of their action. Modulation of their activation or interaction with cofactors as well as inhibiting crucial target gene products may ultimately be exploited to treat various cancers that are dependent on the PEA3 group of ETS transcription factors.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425584      PMCID: PMC3362686          DOI: 10.1016/j.bbcan.2012.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  180 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

Review 2.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

3.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Authors:  Jindan Yu; Jianjun Yu; Ram-Shankar Mani; Qi Cao; Chad J Brenner; Xuhong Cao; Xiaoju Wang; Longtao Wu; James Li; Ming Hu; Yusong Gong; Hong Cheng; Bharathi Laxman; Adaikkalam Vellaichamy; Sunita Shankar; Yong Li; Saravana M Dhanasekaran; Roger Morey; Terrence Barrette; Robert J Lonigro; Scott A Tomlins; Sooryanarayana Varambally; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

4.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Authors:  Peter C Hollenhorst; Mary W Ferris; Megan A Hull; Heejoon Chae; Sun Kim; Barbara J Graves
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

5.  Her-2-neu expression and progression toward androgen independence in human prostate cancer.

Authors:  S Signoretti; R Montironi; J Manola; A Altimari; C Tam; G Bubley; S Balk; G Thomas; I Kaplan; L Hlatky; P Hahnfeldt; P Kantoff; M Loda
Journal:  J Natl Cancer Inst       Date:  2000-12-06       Impact factor: 13.506

6.  Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion.

Authors:  H Hiroumi; H Dosaka-Akita; K Yoshida; M Shindoh; T Ohbuchi; K Fujinaga; M Nishimura
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

7.  PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.

Authors:  R Keld; B Guo; P Downey; R Cummins; C Gulmann; Y S Ang; A D Sharrocks
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

Review 8.  Managing prostate cancer: the role of hormone therapy.

Authors:  Michelle L Ramirez; Thomas E Keane; Christopher P Evans
Journal:  Can J Urol       Date:  2007-12       Impact factor: 1.344

9.  Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  J Biol Chem       Date:  2004-01-27       Impact factor: 5.157

10.  The oncogenic EWS-FLI1 protein binds in vivo GGAA microsatellite sequences with potential transcriptional activation function.

Authors:  Noëlle Guillon; Franck Tirode; Valentina Boeva; Andrei Zynovyev; Emmanuel Barillot; Olivier Delattre
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

View more
  115 in total

1.  Tumor heterogeneity-induced signaling regulates SCLC metastasis.

Authors:  Min-chul Kwon; Anton Berns
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.

Authors:  Mausam Ghosh; Meredith Lane; Elizabeth Krizman; Rita Sattler; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurochem       Date:  2015-11-24       Impact factor: 5.372

3.  Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.

Authors:  Sumin Han; J Chad Brenner; Aaron Sabolch; Will Jackson; Corey Speers; Kari Wilder-Romans; Karen E Knudsen; Theodore S Lawrence; Arul M Chinnaiyan; Felix Y Feng
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

4.  Mitochondrial Membrane Potential Regulates Nuclear Gene Expression in Macrophages Exposed to Prostaglandin E2.

Authors:  David E Sanin; Mai Matsushita; Ramon I Klein Geltink; Katarzyna M Grzes; Nikki van Teijlingen Bakker; Mauro Corrado; Agnieszka M Kabat; Michael D Buck; Jing Qiu; Simon J Lawless; Alanna M Cameron; Matteo Villa; Francesc Baixauli; Annette E Patterson; Fabian Hässler; Jonathan D Curtis; Christina M O'Neill; David O'Sullivan; Duojiao Wu; Gerhard Mittler; Stanley Ching-Cheng Huang; Erika L Pearce; Edward J Pearce
Journal:  Immunity       Date:  2018-12-18       Impact factor: 31.745

5.  ELF3 is a repressor of androgen receptor action in prostate cancer cells.

Authors:  A Shatnawi; J D Norris; C Chaveroux; J S Jasper; A B Sherk; D P McDonnell; V Giguère
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

6.  Extracellular signal-regulated kinase signaling regulates the opposing roles of JUN family transcription factors at ETS/AP-1 sites and in cell migration.

Authors:  Nagarathinam Selvaraj; Justin A Budka; Mary W Ferris; Joshua P Plotnik; Peter C Hollenhorst
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

7.  The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.

Authors:  J S Fowles; D D Dailey; D L Gustafson; D H Thamm; D L Duval
Journal:  Vet Comp Oncol       Date:  2016-05-19       Impact factor: 2.613

8.  Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.

Authors:  Yin P Hung; Christopher Dm Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

9.  ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.

Authors:  Nikhil Tyagi; Sachin K Deshmukh; Sanjeev K Srivastava; Shafquat Azim; Aamir Ahmad; Ahmed Al-Ghadhban; Ajay P Singh; James E Carter; Bin Wang; Seema Singh
Journal:  Mol Cancer Res       Date:  2017-11-08       Impact factor: 5.852

10.  ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.

Authors:  Sook Shin; Sangphil Oh; Seayoon An; Ralf Janknecht
Journal:  Oncol Rep       Date:  2012-10-16       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.